Market News AIOpen the app

PHAT stock news · Phathom Pharmaceuticals

Stories about Phathom Pharmaceuticals (PHAT) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for PHAT

Follow Phathom Pharmaceuticals (PHAT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for PHAT
Free on the App Store and Google Play, or on the web.
  1. Nov 3, 2026, 7:30 PM ET · Market

    Phathom Pharmaceuticals started a program that lets some patients get VOQUEZNA for free.

    Good for PHAT

    Phathom now lets eligible patients get VOQUEZNA for as little as $0 per fill, with delivery and insurance-approval help. This may support use.

  2. Oct 23, 2026, 5:15 PM ET · Trial

    Phathom Pharmaceuticals says BDR Pharmaceuticals is suing the FDA over a drug application.

    Bad for PHAT

    Phathom reported BDR's suit against the FDA over VOQUEZNA's protection, risking earlier generic competition. The FDA still recognizes that protection, but the suit puts Phathom's sales at risk.